Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home packs of HIV post-exposure prophylaxis for sexual exposure (PEPSE)
2013-004809-24Phase 4Unknown
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of maraviroc, emtricitabine and tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Time from HIV sexual risk exposure to initiation of PEPSE. Status: unknown.
02
Drugs
maravirocemtricitabinetenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2013-004809-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004809-24.